Transform Wealth LLC Has $1.35 Million Stock Holdings in The Allstate Co. (NYSE:ALL)

Transform Wealth LLC lessened its holdings in shares of The Allstate Co. (NYSE:ALL) by 3.6% in the second quarter, Holdings Channel.com reports. The fund owned 8,410 shares of the insurance provider’s stock after selling 315 shares during the quarter. Transform Wealth LLC’s holdings in Allstate were worth $1,350,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Confluence Wealth Services Inc. grew its holdings in Allstate by 0.9% during the 1st quarter. Confluence Wealth Services Inc. now owns 7,547 shares of the insurance provider’s stock worth $1,306,000 after acquiring an additional 65 shares during the period. Brighton Jones LLC grew its holdings in Allstate by 1.9% during the 4th quarter. Brighton Jones LLC now owns 3,862 shares of the insurance provider’s stock worth $541,000 after acquiring an additional 71 shares during the period. SVB Wealth LLC grew its holdings in Allstate by 1.2% during the 4th quarter. SVB Wealth LLC now owns 6,169 shares of the insurance provider’s stock worth $864,000 after acquiring an additional 72 shares during the period. Versant Capital Management Inc grew its holdings in Allstate by 70.9% during the 2nd quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock worth $30,000 after acquiring an additional 78 shares during the period. Finally, St. Johns Investment Management Company LLC grew its holdings in Allstate by 2.2% during the 4th quarter. St. Johns Investment Management Company LLC now owns 3,955 shares of the insurance provider’s stock worth $554,000 after acquiring an additional 85 shares during the period. Institutional investors and hedge funds own 76.47% of the company’s stock.

Allstate Trading Up 0.2 %

ALL opened at $171.35 on Tuesday. The firm’s fifty day simple moving average is $165.34 and its 200 day simple moving average is $164.96. The Allstate Co. has a 12 month low of $104.29 and a 12 month high of $180.87. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.49. The stock has a market capitalization of $45.22 billion, a P/E ratio of 37.83, a P/E/G ratio of 1.86 and a beta of 0.48.

Allstate (NYSE:ALL) last posted its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $1.61 EPS for the quarter, topping analysts’ consensus estimates of $0.33 by $1.28. Allstate had a net margin of 5.03% and a return on equity of 24.05%. The company had revenue of $15.71 billion during the quarter, compared to the consensus estimate of $14.04 billion. During the same period in the prior year, the business posted ($4.42) EPS. The company’s quarterly revenue was up 12.4% on a year-over-year basis. As a group, research analysts anticipate that The Allstate Co. will post 13.64 EPS for the current fiscal year.

Allstate Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 1st. Stockholders of record on Friday, August 30th will be paid a dividend of $0.92 per share. The ex-dividend date of this dividend is Friday, August 30th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 2.15%. Allstate’s dividend payout ratio is 81.24%.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. BMO Capital Markets lifted their target price on shares of Allstate from $191.00 to $205.00 and gave the stock an “outperform” rating in a report on Monday, August 5th. Morgan Stanley reduced their price target on shares of Allstate from $205.00 to $200.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 10th. The Goldman Sachs Group lifted their price target on shares of Allstate from $197.00 to $199.00 and gave the stock a “buy” rating in a research report on Friday, July 19th. Bank of America lifted their price target on shares of Allstate from $213.00 to $226.00 and gave the stock a “buy” rating in a research report on Thursday, August 1st. Finally, StockNews.com cut shares of Allstate from a “strong-buy” rating to a “buy” rating in a research report on Friday. Three equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $186.29.

Insider Transactions at Allstate

In other news, insider Suren Gupta sold 45,775 shares of the stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $177.28, for a total transaction of $8,114,992.00. Following the completion of the transaction, the insider now directly owns 89,930 shares in the company, valued at approximately $15,942,790.40. The transaction was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 1.80% of the company’s stock.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.